STOCK TITAN

AWH Files DEA Registration Applications for State-Licensed Medical Cannabis Operations

(Neutral)
Tags

Ascend Wellness Holdings (AAWH) filed applications with the DEA to register certain state-licensed medical cannabis operations under the expedited pathway linked to rescheduling medical marijuana to Schedule III. The applications cover dispensaries serving medical patients across Ascend’s core markets, spanning 51 retail locations and over 260,000 square feet of cultivation, processing, and manufacturing space.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – AAWH

+6.77%
+6.77% Session close to close

In the Jun 30 session, AAWH gained 6.77%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

NEW YORK, June 30, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator and consumer packaged goods company, today announced that it has filed applications with the U.S. Drug Enforcement Administration ("DEA") to register certain state-licensed medical cannabis operations under the expedited registration pathway established in connection with the rescheduling of medical marijuana to Schedule III of the Controlled Substances Act.

"This is an important first step for medical cannabis patients and the medical community, while laying the groundwork for broader normalization across the industry," said Sam Brill, CEO & Director of AWH. "We remain optimistic about what could come next as the DEA hearing on adult-use cannabis rescheduling gets underway. Further reform will help establish a more level playing field for cannabis operators and could align the industry with more economic opportunities and regulatory frameworks available to traditional businesses."

The applications cover dispensary operations supporting medical cannabis patients across the Company's core markets. AWH's footprint spans 51 retail locations across seven states, including partner-owned and operated stores, and includes more than 260,000 square feet of canopy across its six cultivation, processing, and manufacturing facilities.

About Ascend Wellness Holdings, Inc.

AWH is a vertically integrated cannabis operator with assets in Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania. AWH owns and operates state-of-the-art cultivation facilities, growing award-winning strains and producing a curated selection of products for retail and wholesale customers. AWH produces and distributes its in-house Ozone, Simply Herb, High Wired, Honor Roll, Royale, and Effin' branded products. For more information about AWH, visit www.awholdings.com.

Cautionary Note Regarding Forward-Looking Information

This news release contains forward-looking information and forward-looking statements (collectively, "forward-looking statements") within the meaning of applicable U.S. and Canadian securities laws, which may include, but are not limited to, the plans, intentions, expectations, estimates, and beliefs of the Company. Words such as "expects", "continue(s)", "may", "will", "anticipates", "believes", "estimates", "plans", "projects", "outlook", "guidance" and "intends" or similar expressions are intended to identify forward-looking statements. Forward-looking statements in this press release also include, without limitation, statements regarding the Company's filing of applications with the U.S. DEA to register certain state-licensed medical operations under the expedited registration pathway established in connection with the rescheduling of medical marijuana to Schedule III of the Controlled Substances Act, as well as the potential impact of such developments on the Company's operations and broader industry.

We caution investors that any such forward-looking statements are based on the Company's current projections and expectations about future events and financial trends, the receipt of all required regulatory approvals, and on certain assumptions, estimates, and analysis made by the Company in light of the experience of the Company and its perception of historical trends, current conditions, and expected future developments and other factors that management believes are appropriate, including, with respect to statements regarding rescheduling, assumptions about the timing and final form of any such rescheduling.

Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein. Such factors include, without limitation, the risks and uncertainties identified in the Company's most recently filed Annual Report on Form 10-K, as updated in subsequently filed Quarterly Reports on Form 10-Q, as applicable, and in the Company's other reports and filings with the applicable Canadian securities administrators on its profile on SEDAR+ at www.sedarplus.ca and the SEC on its profile on EDGAR at www.sec.gov. Readers are cautioned that the foregoing list of factors is not exhaustive. Although the Company believes that any forward-looking statements herein are reasonable, in light of the use of assumptions and the significant risks and uncertainties inherent in such statements, there can be no assurance that any such forward-looking statements will prove to be accurate, and accordingly readers are advised to rely on their own evaluation of such risks and uncertainties and should not place undue reliance upon such forward-looking statements. Any forward-looking statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward-looking statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws. No securities regulator nor the Canadian Securities Exchange has reviewed, approved, or disapproved the content of this press release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/awh-files-dea-registration-applications-for-state-licensed-medical-cannabis-operations-302813902.html

SOURCE Ascend Wellness Holdings, Inc.

FAQ

What did Ascend Wellness Holdings (AAWH) announce on June 30, 2026?

Ascend Wellness Holdings announced it has filed DEA registration applications for certain state-licensed medical cannabis operations. According to Ascend, these filings use the expedited pathway tied to medical marijuana’s rescheduling to Schedule III under the Controlled Substances Act, focusing on medical dispensary operations.

How many locations and facilities does Ascend Wellness Holdings (AAWH) operate?

Ascend Wellness Holdings reports a footprint of 51 retail locations across seven states. According to Ascend, the company also operates more than 260,000 square feet of canopy across six cultivation, processing, and manufacturing facilities supporting its medical and adult-use cannabis product portfolio.

Which markets are included in Ascend Wellness Holdings (AAWH) medical cannabis DEA applications?

The DEA applications cover dispensary operations supporting medical cannabis patients across Ascend’s core markets. According to Ascend, its operating footprint spans Illinois, Maryland, Massachusetts, Michigan, New Jersey, Ohio, and Pennsylvania through a mix of company-owned and partner-owned retail locations.

How does the DEA Schedule III expedited registration pathway affect Ascend Wellness Holdings (AAWH)?

Ascend Wellness Holdings is using the DEA’s expedited registration pathway created after medical marijuana was rescheduled to Schedule III. According to Ascend, registering eligible medical operations may support patients and the medical community while helping lay groundwork for broader industry normalization and future regulatory reforms.

What cannabis brands does Ascend Wellness Holdings (AAWH) produce and distribute?

Ascend Wellness Holdings produces and distributes several in-house cannabis brands. According to Ascend, its portfolio includes Ozone, Simply Herb, High Wired, Honor Roll, Royale, and Effin’ branded products, offered through its vertically integrated cultivation, processing, and retail operations in its seven-state footprint.

What is the strategic focus of Ascend Wellness Holdings (AAWH) as a cannabis company?

Ascend Wellness Holdings focuses on being a vertically integrated, multi-state cannabis operator and consumer packaged goods company. According to Ascend, it operates state-of-the-art cultivation facilities, grows award-winning strains, and offers a curated selection of products for both retail and wholesale cannabis customers.